Informa (LON:INF) Price Target Raised to GBX 1,290

Informa (LON:INF) had its price target raised by research analysts at Deutsche Bank Aktiengesellschaft from GBX 1,140 to GBX 1,290 in a report issued on Friday, Digital Look reports. The brokerage presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 42.54% from the company’s previous close.

A number of other equities research analysts also recently issued reports on INF. JPMorgan Chase & Co. reduced their price target on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating on the stock in a research report on Thursday, July 2nd. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 1,040 price objective on shares of Informa in a report on Thursday. Finally, Citigroup lifted their price objective on Informa from GBX 990 to GBX 1,090 and gave the company a “buy” rating in a report on Wednesday, August 12th. Six investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of GBX 1,160.

Informa Stock Performance

LON INF opened at GBX 905 on Friday. The firm has a 50-day moving average price of GBX 893.37 and a two-hundred day moving average price of GBX 852.74. Informa has a 12-month low of GBX 719 and a 12-month high of GBX 1,000. The company has a market capitalization of £11.31 billion, a P/E ratio of 52.92, a P/E/G ratio of 0.75 and a beta of 0.68. The company has a quick ratio of 1.70, a current ratio of 0.55 and a debt-to-equity ratio of 64.99.

Informa (LON:INF) last announced its earnings results on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. Analysts anticipate that Informa will post 59.3240265 earnings per share for the current year.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.